The in vitro study of neural progenitors is based around the idea that defined culture conditions can emulate an environment which maintains an undifferentiated state and self-renewal capability of explanted progenitor cells, culminating in the growth of neurospheres. Neurosphere culture systems are used to study cells of physiological origin as well as transformed cells. In the case of the cerebellar granule cell lineage, neurosphere cultures have been produced from medulloblastoma tumors, while non-transformed granule progenitors are reported to be transient in vitro. SHH signaling is a key signaling pathway with roles in morphogenesis and cell proliferation in the central nervous system, in particular, involved in mitogenic signaling within the context of postnatal cerebellar granule cell expansion. In this paper, I demonstrate that in addition to commonly used mitogens such as EGF and bFGF, the SHH pathway agonist SAG, as well as genetic activation of SHH signaling by PTCH1 deletion, can lead to the growth of neurospheres from postnatal day 7 (p7) cerebellar explants.
Introduction
Development of the mammalian cerebellum continues after the birth of the animals, particularly manifesting itself in the form of a transitory layer of proliferating cells on the surface of the developing cerebellum, i.e. the external granule layer (EGL). Cells within the EGL undergo cell division, migration and finally terminally differentiate to give rise to the internal granule layer (IGL). The completed IGL houses the population of mature cerebellar granule neurons, which are glutamatergic neurons that are the most abundant cells in the mammalian body.
Proliferation of cerebellar granule progenitors (GCPs) is transient and is finely regulated by a plethora of extracellular signals, of which sonic hedgehog (SHH) signaling has been demonstrated as being necessary and sufficient to drive GCP expansion (Wechsler-Reya and Scott, 1999) .
. However other signals have been demonstrated to either potentiate this response, such as IGF-1 (Browd et al., 2006) , or to contribute to the attenuation of the SHH dependent mitogenic response (Rios et al., 2004) . During development of the cerebellum, proliferation of GCPs eventually ceases at approximately 5 months post-partum in humans and in mice approximately 21 days after birth. Prolonged proliferation due to either enhancement of mitogenic signaling or disruption of active inhibitory cues has been linked to the genesis of type 2 medulloblastoma (Northcott et al., 2012) .
The transient proliferation of GCPs has been extensively studied in vitro and the reported methods of culture of these cells lead to the production of primary cultures, which recapitulate the limited proliferative capability of GCP lineage cells as also displayed during normal post-natal development (Miyazawa et al., 2000; Wechsler-Reya and Scott, 1999) . The observation that GCPs cease proliferation and differentiate in primary cultures despite even prolonged treatment with exogenous SHH protein or agonists of the SHH pathway has led to the hypothesis that GCPs posses intrinsic mechanisms of regulation of cell cycle exit and differentiation (Kessler et al., 2009 ).
In addition to being cultured as adherent cells, neural progenitors can also be cultured in defined media without serum where they exist as floating, proliferating cell aggregates known as neurospheres. Neurosphere cultures were pioneered in the 1990s (Reynolds and Weiss, 1992) and are often used as models of neural stem cells. This is due to their properties, which match the operative definition of a neural stem cell, these being multi-potency and extensive self-renewal capabilities (Pastrana et al., 2011; Reynolds and Weiss, 1992) .
Neural progenitors that undergo rounds of clonal expansion followed by differentiation are known as transit amplifying (TA) progenitor cells (Butts et al., 2014) . In addition to GCPs, TA cells have been identified in other systems of post-natal neural development such as the dentate gyrus of the hippocampus and the adult sub-ventricular zone (SVZ) (Capdevila et al., 2016; Gonçalves et al., 2016 ).
Interestingly, in vivo studies have cast doubt on the in vivo stem cell identity of in vitro cultured neurospheres (Pastrana et al., 2011) . This is best exemplifed by Doetsch et. al. in which the authors develop a labeling strategy to retrospectively identify the origin of SVZ derived neurospheres as being not of the stem cell compartment but of the TA compartment (Doetsch et al., 2002) .
The cellular hierarchies which determine the dynamics of neural tissue are also relevant in the context of cancer biology. In that context of brain tumors, it has been reported that tumor initiating cells or tumor maintaining cells posses properties of immature neural progenitors (Ahlfeld et al., 2013; Capdevila et al., 2016; Vanner et al., 2014) . Further, diverse methods have been proposed for the culture of brain tumor derived cells (Rahman et al., 2015) . Choice of opportune conditions can lead to more or less relevant cell lines (Sasai et al., 2006) .
In this work I explore alternate culture conditions for GCP lineage cells. I begin with characterization of cell cultures obtained from murine medulloblastoma and extend these studies to non-transformed GCPs. Importantly, I demonstrate that GCPs can be cultured as neurospheres solely under conditions which permit activity of the SHH signaling pathway. Further, I discover that these cell cultures can be maintained for extensive periods, remaining dependent on SHH signaling. Additionally, under these conditions, GCP cells maintain the potential to differentiate into post-mitotic granule cells.
Materials and Methods

Establishment of cultures from murine central nervous system
Postnatal day 7 (p7) mice were sacrificed by decapitation and tissues were collected in HBSS supplemented with 0.5% glucose and penicillin-streptomycin, grossly triturated with serological pipette and treated with DNAse I to a final concentration of 0.04% for 20 min. Finally, cell aggregates were mechanically dissociated using pipettes of decreasing bore size to obtain a singlecell suspension. SCs were cultured as neurospheres in selective medium after centrifugation, DMEM/F12 supplemented with 0.6% glucose, 25 µg/ml insulin, 60 μg/ml N-acetyl-L-cystein, 2 μg/ml heparin, 20 ng/ml EGF, 20 ng/ml bFGF (Peprotech, Rocky Hill, NJ) or 1µM SAG (Adipogene), 1X penicillin-streptomycin and B27 supplement without vitamin A. SAG dosage was 1µM unless otherwise specified.
For differentiation, cells were mechanically dissociated and plated on polylysinated cell culture dishes in the following medium : Neurobasal (Invitrogen) supplemented with glutamine, penicillinstreptomycin, 0.5% fetal bovine serum and B27 supplement.
Clonogenic assay
Cells were pelleted and dissociated by incubation with Accutase (Sigma Aldrich) in concomitance with continuous pipetting to obtain a single cell suspension. Cells were counted with a hemocytometer and were diluted to obtain a suspension concentrated 0.267 cells/µl. Cell suspension was distributed amongst a 96 well plate, pipetting 75µl into each well.
Respective treatments were prepared with double the final concentration and 75 µl were added to each well for a final volume of 150µl concentrated 0.134 cells/µl, for a total of 20 cells per well.
After 3 days medium was replenished and an additional 3 days later the number of spheres per well was recorded. Exhibited data represents averages of 2 independent experiments, each having 24 wells per treatment point.
RNA preparation and quantitative reverse transcription-PCR
Total RNA extraction was carried out with TRIzol reagent (Invitrogen). For quantitative reverse transcription-PCR (QPCR), total RNA (1µg) was reverse transcribed using the Gene Amp kit (Applied Biosystems) and subjected to PCR amplification using SYBR Green PCR Master Mix Images were analyzed and scored using ImageJ.
Results
Generation of relevant murine tumor spheres from conditional knockout disease model
It was recently reported that murine primary MB explants from the PTCH +/-model could be cultured as tumor spheres which maintain activity of the SHH pathway (Zhao et al., 2015) . I extend this approach to another model of murine SHH type MB, the ATOH1-CRE; PTCH1 fl/fl mouse. As reported previously, cells proliferated in the form of spheres. These cells, herein named SHH medulloblastoma tumor spheres (MBSHH-TS) express relevant lineage specific and SHH pathway associated genes and consequently cluster together with their respective primary tumor tissues of origin (Fig. 1a) . Conversely, MBSHH-TS cell lines are readily distinguishable from the type 4 MB model GTML. MBSHH-TS cells further demonstrated nanomolar sensitivity to the smoothened inhibitor vismodegib, as shown by XTT assay (Fig. 1b) . To confirm that vismodegib sensitivity is due to inhibition of the SHH pathway, I assayed the expression of NMYC and GLI1 by western blot, both of which decreased in a dose dependent manner (Fig. 1c) .
Further, cleaved PARP1 levels increased in a dose dependent manner, thus recapitulating type 2 MB behavior in this in vitro model. In addition to the aforementioned western blot data I also assayed the expression of gli1, ptch1, ptch2 and hhip genes, all of which responded negatively to vismodegib treatment (Fig. 1d) .
To underline the novelty and significance of these types of cell lines, I compare MBSHH-TS cells to cells from the same tumor explant, which were cultured in neurosphere medium supplemented with EGF and bFGF. These cells do give rise to neurospheres, however such cells do not express detectable levels of either GLI1 or ZIC1 protein (Fig. 1e) , indicating that they may not be relevant towards the study of SHH subtype medulloblastoma.
The finding that growth factors may not support SHH signaling reflects literature which describes that bFGF treatment inhibits the signaling pathway (Emmenegger et al., 2013) . Consistent with these observations, treatment of established MBSHH-TS cells with either bFGF or serum led to diminishment of GLI1 protein expression and the SHH pathway downstream effector NMYC (Fig.   1f ).
The postnatal cerebellum supports generation of novel neurosphere cultures which express an activated SHH pathway
In the context of the forebrain, the discovery that cells could be cultured as neurospheres eventually led to another discovery, in the form that brain tumors, such as glioblastoma multiforme (GBM), could also lead to formation of such cultures (Vescovi et al., 2006) . There exists, therefore, some kind of duality between transformed and non-transformed cells, in which the same culture conditions can lead to generation of different cell lines based on physiological or diseased status of the starting material.
To explore the possibility that this duality could be extended to the context of SHH type MB and non-transformed GCP cells, I reasoned that cells originating from postnatal murine cerebellar explants should be cultured under conditions which support SHH pathway activation. I therefore exposed cell pools originating from dissociated p7 murine cerebella to serum-free neurosphere culture conditions, supplemented with the growth factors bFGF and EGF (EF conditions) and/or SAG, a small molecule agonist of the SHH signaling pathway.
I observed that after 7 days in culture, primary explants treated with EF conditions lost expression of the SHH pathway mediator GLI1 while cells exposed to SAG maintained GLI1 expression (Fig.   2a) . Further, I observe that GLI1 expression is also undetectable in cells exposed to EF together with SAG, thus confirming previous observations that growth factor signaling can actively inhibit SHH signaling. In addition to measuring GLI1 protein levels under these conditions, I also carried out a clonogenic assay in order to quantify the formation of neurospheres under the aforementioned conditions.
I observe formation of spheres under all the experimental conditions tested, while no clonogenicity was observed in control (DMSO) treated explants (Fig. 2b) . I therefore conclude that while diverse culture conditions can give rise to neurosphere cultures from the developing murine cerebellum, these cultures only express an active SHH pathway when cultured in the presence of SAG without the other tested growth factors.
After having established SHH pathway expressing neurospheres, I challenged cerebellar explants with a lower dose of SAG to investigate sensitivity to SAG levels. Interestingly, 0.2µM SAG led to significantly decreased sphere formation from primary cerebellar cells (Fig. 2c) .
Neurospheres express markers of neural progenitors and stem cells (Pastrana et al., 2011) . To assess whether these novel SAG exposed neurospheres mimic this hallmark I assayed expression of the neural progenitor associated gene nestin, as well as the stem-cell factors sox2 and it´s binding partners pou5f1 (oct4) and pou3f2 (brn2), relative to the murine lymphoblastoid line YAC1. SAG exposed cells expressed all the aforementioned markers, even if sox2 was expressed at lower levels (Fig.2d) .
Neurospheres are known for their extensive proliferative capability, while GCP cultures have normally been described as being of transient nature, consistent with their developmental origin.
This led me to investigate and, subsequently, challenge the long-term proliferative properties of my novel SAG grown neurospheres by measuring clongenicity for a period of 10 weeks, corresponding to 20 passages. I observe that SAG supports continuous clonogenicity of these cells throughout the duration of the experiment (Fig. 2e) .
I chose the time frame of 10 weeks for this experiment, however, I report that these cells proliferate indefinitely, as far as I can judge. The extensive proliferation of GCP lineage neurospheres permits the establishment of long-lived cell lines from cerebellar explants, these lines will be referred to as murine SAG induced spheres (mSS) from now on, while neurospheres grown in EF conditions will be referred to as murine EGF/bFGF dependent spheres (mEFS).
Hedgehog pathway active, cerebellum derived neurospheres belong to the GCP lineage
Next, I sought to investigate the identity of SAG dependent neurospheres. Murine neurospheres have been known to originate from diverse sites along the neuraxis, including the sub-ventricular zone (SVZ). To inquire the specificity of establishment of SAG dependent neurospheres as a function of anatomic location I exposed SVZ and cerebellar explants from p7 brains to either EF conditions or SAG and assayed sphere formation in terms of clonogenicity.
While I replicate the observation that neurospheres are generated from the SVZ and cerebellum in the presence of the two growth factors (Lee et al., 2005) , SAG could only lead to the generation of neurospheres from the cerebellum (Fig. 3a) . This observation led me to hypothesize that the in vivo origin on these cells could be a cell type unique to the cerebellum at this developmental stage.
As proliferating GCP cells are an abundant cell type in the post-natal murine cerebellum I established cultures under EF conditions, as well as SAG treatment and monitored the expression of ZIC1 protein and atoh1 transcript during the course of the initial culture, as these are both reported as being markers of the GCP lineage. I observe that ZIC1 protein levels gradually decrease in the presence of EF conditions, being undetectable after 6 days, while ZIC1 levels remain detectable after 1 month, concomitant with increased levels of GLI1 (Fig. 3b, top) . Concordantly, ATOH1
transcript levels were gradually enriched in SAG exposed cells while they gradually decreased under EF conditions (Fig. 3b, bottom) . The gradual increase in GCP lineage markers, of which atoh1 and zic1 are not transcriptionally activated by the SHH pathway, in SAG exposed cells suggests enrichment of GCP cells at the expense of SAG non-responsive cells.
To further confirm that SAG responsive cells are of the GCP lineage, I investigated if SAG treatment could be substituted with genetic activation of the SHH signaling pathway in the GCP lineage. In ATOH1-CRE; PTCH1 fl/fl mice CRE recombinase expression is driven in cells of the GCP lineage (Yang et al., 2008) . Clonogenic assay was carried out on cells originating from p7 cerebella of either ATOH1-CRE; PTCH1 fl/fl mice or WT littermates and clonogenicity was observed with SAG treatment, while only conditional KO cells gave rise to spheres in the absence of SAG (Fig. 3c ), which will be referred to as murine PTCH KO derived spheres (mPS). Therefore, I maintain, that cells of the GCP lineage respond to SAG treatment with SHH signaling pathway activation and proliferation under these conditions. To further establish the identity of the GCP derived cell lines with respect to mEF neurospheres I assayed expression of key SHH pathway components (gli1, gli2, nmyc, ptch1) and GCP lineage markers (atoh1, zic1). All these markers were expressed similarly in mSS and mPS cells, while expression was very low in mEF cells (Fig.   3d ).
mSS cells continuously require SHH pathway stimuation
To assay the requirement of mSS cells for exogenous agonist of the SHH signaling pathway I challenged mSS cells, which had been in culture for over 10 weeks, by removing SAG from the culture medium. I observed a marked decrease in clonogenic capability (Fig. 4a) .
To further confirm the continuous requirement for Smoothened stimulation for SHH pathway activation and proliferation of mSS cells, I treated these cells with either KAAD-cyclopamine or GDC-0449, which are inhibitors of the Smoothened protein.
In agreement with the above observations, clonogenicity diminishes with concomitant downregulation of SHH pathway components in terms or transcript and protein levels (Fig. 4b) .
mSS cells maintain neural lineage commitment after long-term culture
It has been reported that the plasticity of neural progenitors can be modified after long periods of time in cell culture (Conti and Cattaneo, 2010) . To assay the capabilities of mSS cells to differentiate in vitro I exposed paired mSS and mEF neurospheres to medium containing serum, a condition reported to promote neurosphere differentiation towards the astrocytic lineage. Both cell types attach to the dish within 24 hours and after 5 days in these conditions mSS cells acquire a bipolar neuronal morphology while mEF neurospheres acquire glial morphology (Fig. 5a ).
To characterize the fate of differentiated neurospheres more precisely I assayed the protein levels of beta3-tubulin and GFAP, markers of neuronal and astrocytic differentiation, respectively. In agreement with the above mentioned morphological changes undergone in differentiation medium mSS cells up-regulated expression of beta3-tubulin, on the other hand mEF neurospheres expressed high levels of GFAP under these conditions (Fig. 5b, top) .
After having established neuronal lineage commitment for mSS cells I assayed expression of gabra2 and atoh1 in differentiated cells. In accordance with the GCP identity of mSS cells, atoh1 transcript levels decreased, while gabra2 levels accumulated upon differentiation (Fig. 5b, 
bottom).
I also analyzed differentiated mEF and mSS cell cultures by immunofluorescence for beta3-tubulin and GFAP. In accord with the mutual exclusivity of GFAP and beta3-tubulin between the two differentiated cell pools, mEFS cells gave rise to a homogeneous population of GFAP positive cells while mSS cells gave rise to a significant majority of beta3-tubulin staining cells (Fig. 5c) . The unlimited proliferation capability of mSS cells were unexpected because GCP cell cultures were previously defined as being transient even in the presence of mitogenic stimuli, such as SHH or the pharmacological smoothened agonist SAG (Miyazawa et al., 2000; Wechsler-Reya and Scott, 1999) . On the other hand, extensive self-renewal of TA cells cultured in neurosphere conditions has been reported also in other contexts of neurogenesis (Doetsch et al., 2002) .
.
As was the case in the context of SHH subtype MB, the choice of cell culture medium was key in maintaining activity of the SHH pathway. Cerebellum derived neurospheres cultured in the presence of EGF and bFGF lose activity of the SHH pathway, which is consistent with previous observations. The fact that mono-layer GCP cultures are limited in their expansion could be due to contact between the cell and the plastic substrate, or serum treatment, which is often included in these protocols.
In the past, MB and SHH research have relied on adhesive cell cultures, such as human tumor derived cell lines or murine 3T3 cells (Götschel et al., 2013; Taipale et al., 2000) . It is significant to note, that these cell lines require hyperconfluecy and low serum conditions before they become receptive to exogenous treatments that activate the SHH pathway. These treatment conditions are not the ideal for cancer relevant experiments, which aim to measure proliferation or invasive capability. Indeed, in this work, in addition to confirming that bFGF will inhibit SHH activity in established MB cell lines and I also make the novel observation that serum treatment also has this effect. This could explain the previously made observation that culturing murine MB cells in DMEM + 10% FBS leads to cell lines that do not express the SHH pathway (Sasai et al., 2006) .
Literature suggests that the SHH inducibility through manipulation of confluency and serum may be mediated by the YAP/TAZ signaling pathway (Tariki et al., 2014) .
The generation of mSS cell lines is significant also due to pairing of such lines with tumor derived cell lines, as it allows for assaying properties that are specific to transformed cells, allowing for discovery of therapeutics targeted specifically to cancer cells. Current treatments for medulloblastoma often leave patients neurologically impaired (Palmer et al., 2001 (Palmer et al., , 2007 , therefore it is a priority to optimize therapeutic index for treatments to this disease. An attractive experimental design in this spirit would be pairings of conditional knockout cell lines as used in this work. ATOH1-CRE; PTCH1 fl/fl cell lines could be generated from early postnatal cerebella as well as established tumors, further studies can then be carried out under homogeneous experimental conditions, as neither of these cell lines require additional culture supplementation to proliferate.
The adherence to the physiological lineage of mSS cells after even long periods in culture is notable, because in the context of other types of neurosphere culture extensive proliferation has been shown to deplete neurogenic potential of neural derived progenitor cultures (Conti and Cattaneo, 2010) . mSS cells therefore distinguish themselves from other kinds of neurosphere lines in that they stably adhere to the neural lineage.
The fact that mSS cultures derive from GCP cells strongly suggests that the cultures originate from TA cells which are suspended in the proliferative state through persistent activation of the SHH pathway. The concept that TA cells of neural origin can be easily cultured for long periods of time has also been observed in cells originating from the murine SVZ niche (Doetsch et al., 2002) . In that case, TA cells maintained proliferation in a EGF receptor dependent manner, again highlighting the effect that sustained mitogenic signaling can have on TA cells. Cellular lineages consist of quiescent stem cells and differentiated cells which carry out tissue function. Between these two states, TA cells undergo rapid expansion and therefore may constitute a vulnerability in terms of oncogenic transformation. In the case of the GCP lineage this seems partially to be true because oncogenic mutations even in stem cells manifest only after commitment to the GCP lineage (Schüller et al., 2008; Yang et al., 2008) .
Conclusion
To conclude, in this work I describe how opportune defined cell culture conditions can favor establishment of neurosphere cell lines that adhere to the cerebellar GCP lineage. An important property of these lines is their dependency on mitogenic SHH signaling. Strikingly, neurospheres from normal p7 cerebella proliferate indefinitely in culture, which is unexpected given their normal developmental role as TA cells. Further, these cells, named mSS, remain dependent on exogenous mitogenic stimulus and remain adherent to the GCP lineage when placed under differentiation conditions. Together with their tumor derived counterparts, mSS cells establish an in vitro paradigm for the study of GCP lineage cells under diseased and normal conditions. This paradigm is unique as it respects the requirement of this lineage for mitogenic SHH signaling. 
